Dimethyl fumarate and teriflunomide for multiple sclerosis in a real ‐life setting: a French retrospective cohort study

ConclusionIn this retrospective cohort study, DMF demonstrated significantly better efficacy over 2  years than teriflunomide, but tolerance to teriflunomide was better.

Source: European Journal of Neurology - November 9, 2018 Category: Neurology Authors: S. Cond é, X. Moisset, B. Pereira, M. Zuel, R. Colamarino, M. Maillet‐Vioud, M. Lauxerois, F. Taithe, P. Clavelou, on behalf of the Réseau NeuroSEP Auvergne Tags: Original Article Source Type: research